Abstract
Tumours in the central nervous system (CNS) include metastatic disease and primary tumours which range from highly malignant such as high-grade gliomas to curable tumours which include meningiomas, benign pituitary adenomas and cranial germ-cell tumours. Radiotherapy is the mainstay of primary therapy both in the curative and the palliative setting.
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Thomas DGT, McKeran RO (1990) Clinical manifestations of brain tumours. In: Thomas DGT (ed) Neuro-oncology — primary malignant brain tumours. Edward Arnold, London, 141–147.
MacDonald DR, Cascino TL, Schold SCJ, Cairncross G (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8:1277–1280.
Brazil LC, Thomas R, Laing R et al. (1997) Verbally administered Barthel Index as functional assessment in brain tumour patients. J Neuro-oncol 34, 187–192.
Grant R, Slattery J, Gregor A, Whittle IR (1994) Recording neurological impairment in clinical trials of glioma. J Neuro-oncol 19:37–49.
Osoba D, Aaronson NK, Muller M et al. (1996) The development and psychometric validation of a brain cancer quality-of-life questionnaire for use in combination with general cancer-specific questionnaires. Qual Life Res 5:139–150.
Kristiansen K, Hagen S, Kollevold T et al. (1981) Combined modality therapy of operated astrocytomas grade III and IV. Confirmation of the value of postoperative irradiation and lack of potentiation of bleomycin on survival time: a prospective multicenter trial of the Scandinavian Glioblastoma Study Group. Cancer 47:649–652.
Walker MD, Alexander E, Hunt WE et al. (1978) Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. J Neurosurg 49:333–343.
Bleehen NM, Stenning SP and on behalf of the Medical Research Council Brain Tumour Working Party (1991) A Medical Research Council trial of two radiotherapy doses in the treatment of grades 3 and 4 astrocytoma. Br J Cancer 64:769–774.
Chang CH, Horton J, Schoenfeld D et al. (1983) Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas. Cancer 52:997–1007.
Brada M, Laing R (1994) Radiosurgery/stereotactic external beam radiotherapy for malignant brain tumours: the Royal Marsden experience. In: Wiestier OD, Schlegel U, Schramm J (eds) Molecular neuro-oncology and its impact on the clinical management of brain tumours. Springer-Verlag, Berlin, pp 91–103.
Sneed PK, Larson DA, Gutin PH (1994) Brachytherapy and hyperthermia for malignant astrocytomas. Semin Oncol 21:186–197.
Loeffler J, Alexander E III. (1991) Stereotactic radiosurgery for malignant gliomas. Second International Neuro-oncology Conference, London.
Curran WJ, Scott CB, Weinstein AS et al. (1993) Survival comparison of radiosurgery-eligible and-ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 11:857–862.
Curran WJ, Scott CB, Horton J et al. (1993) Recursive partitioning analysis of prognostic factors in three radiation therapy oncology group malignant glioma trials. J Natl Cancer Inst 85:704–710.
MRC Brain Tumour Working Party (1990) Prognostic factors for high-grade malignant glioma: development of a prognostic index. J Neuro-oncol 9:47–55.
Brada M (1995) Central nervous system tumours. In: Horwich A (ed) Oncology — a multidisciplinary textbook. Chapman and Hall, London, pp 395–416.
Bauman GS, Gaspar LE, Fisher BJ et al. (1994) A prospective study of short-course radiotherapy in poor prognosis glioblastoma multiforme. Int J Radiat Oncol Biol Phys 29:835–839.
Thomas R, James N, Guerrero D et al. (1994) Hypofractionated radiotherapy as palliative treatment in poor prognosis patients with high grade glioma. Radiother Oncol 33:113–116.
Rajan B, Ross GM, Lim CC et al. (1994) Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy. Eur J Cancer 30A:1809–1815.
Moser RP (1988) Surgery for glioma relapse: factors that influence a favourable outcome. Cancer 62:381–390.
Leibel SA, Gutin PH, Wara WM et al. (1989) Survival and quality of life after interstitial implantation of removable high-activity Iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17:1129–1139.
Laing RW, Warrington AP, Graham J et al. (1993) Efficacy and toxicity of fractionated stereotactic radiotherapy in the treatment of recurrent gliomas (phase I/II study). Radiother Oncol 27:22–39.
Vecht CJ, Haaxma-Reiche H, Noordijk EM et al. (1993) Treatment of single brain metastasis: radiotherapy alone or combined with neurosurgery? Ann Neurol 33:583–590.
Shaw EG, Daumas-Duport C, Scheithauer BW et al. (1989) Radiation therapy in the management of low-grade supratentorial astrocytomas. J Neurosurg 70:853–861.
Rajan B, Pickuth D, Ashley S et al. (1994) The management of histologically unverified presumed cerebral gliomas with radiotherapy. Int J Radiat Oncol Biol Phys 28:405–413.
Ostertag C, Warnke P (1991) Interstitial radiotherapy for brain tumours. Br J Neurosurg 5:421–436.
Diener-West M, Dobbins TW, Phillips TL, Nelson DF (1989) Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 16:669–673.
Borgelt B, Gelber R, Kramer S et al. (1980) The palliation of brain metastases: final results of the first two studies by the radiation therapy oncology group. Int J Radiat Oncol Biol Phys 6:1–9.
Haie-Meder C, Pallae-Cosset B, Laplanche A et al. (1993) Results of a randomized clinical trial comparing two radiation schedules in the palliative treatment of brain metastases. Radiother Oncol 26:111–116.
Patchell R, Tibbs P, Walsh J et al. (1990) A randomised trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500.
Smalley SR, Laws ER, OcTallon JR, Shaw EG, Schray MF (1992) Resection for solitary brain metastases. J Neurosurg 77:531–540.
Noordijk EM, Vecht CJ, Haaxma-Reiche H et al. (1994) The choice of treatment of single brain metastasis should be based on extracranial tumour activity and age. Int J Radiat Oncol Biol Phys 29:711–717.
Engenhart R, Kimmig BN, Hover KH et al. (1993) Long-term follow-up for brain metastases treated by percutaneous stereotactic single high-dose irradiation. Cancer 71:1353–1361.
Byrne TN (1992) Spinal cord compression from epidural metastases. N Engl J Med 327:614–619.
Helweg-Larsen S, Sorensen PS (1994) Symptoms and signs in metastatic spinal cord compression: a study of progression from first symptom until diagnosis in 153 patients. Eur J Cancer 3:396–398.
Kato AM Ushio Y, Hayakawa T et al. (1985) Circulatory disturbance of the spinal cord with epidural neoplasm in rats. J Neurosurg 63:260–265.
Sorensen PS, Helweg-Larsen S, Mouridsen H, Hansen HH (1994) Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy: a randomised trial. Eur J Cancer 1:22–27.
Gilbert RW, Kim J-H and Posner JB (1978) Epidural spinal cord compression from metastatic tumour: diagnosis and treatment. Ann Neurol 3:40–51.
Hill ME, Richards MA, Gregory WM, Smith P, Rubens RD (1993) Spinal cord compression in breast cancer: a review of 70 cases. Br J Cancer 68:969–973.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag London Limited
About this chapter
Cite this chapter
Barton, R., Brazil, L., Brada, M. (1998). Non-Curative Radiotherapy for Neurological Cancer. In: Slevin, M.L., Tate, T. (eds) Cancer: How Worthwhile is Non-Curative Treatment?. Focus on Cancer. Springer, London. https://doi.org/10.1007/978-1-4471-1509-0_12
Download citation
DOI: https://doi.org/10.1007/978-1-4471-1509-0_12
Publisher Name: Springer, London
Print ISBN: 978-3-540-76083-2
Online ISBN: 978-1-4471-1509-0
eBook Packages: Springer Book Archive